Skip to main content
HCPCS Q9950 · Level II · Part B drug

Q9950: sulfur hexafluoride lipid microspheres (Lumason, Lumason Novaplus), HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for Q9950

Billing unit
1 ML
Inj sulf hexa lipid microsph
ASP payment limit
$18.052
October 2026; -0.4% vs July 2026
Practitioner MUE
5
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
1
4 states

TL;DR

HCPCS Q9950 is the Level II code for Injection, sulfur hexafluoride lipid microspheres, per ml, billed per 1 ML. The Medicare Part B ASP payment limit for October 2026 is $18.052 per billing unit, down 0.4% from July 2026. The practitioner MUE allows up to 5 units per date of service (MAI 3), so a full 5-unit day is $90.26 at the current limit. Under OPPS it carries status indicator N. Diagnostic agents are usually packaged under OPPS (status N) in the hospital outpatient setting, so separate payment applies mainly in the physician office under Part B. The ASP crosswalk maps 4 NDCs to it, sold as Lumason, Lumason Novaplus by Bracco Diagnostics Inc. 1 Medicare coverage article lists the code across 4 states, including A58503.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for Q9950 at $18.052 per 1 ML for October 2026, derived from manufacturer average sales price plus 6%, compared with $18.126 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for Q9950
QuarterPayment limitPerCoinsurance
October 2026$18.0521 ML20%
July 2026$18.1261 ML—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 4 NDCs from 1 labeler to Q9950. Report the NDC in the claim's drug segment and bill the number of Q9950 units that equals the quantity administered divided by 1 ML; the last column gives units per full package.

NDCs that crosswalk to Q9950
NDCDrug nameLabelerPackage sizeBilling units / package
00270-7097-07LumasonBracco Diagnostics Inc.5 × 20100
00270-7097-08Lumason NovaplusBracco Diagnostics Inc.5 × 20100
00270-7099-16LumasonBracco Diagnostics Inc.5 × 525
00270-7099-73Lumason NovaplusBracco Diagnostics Inc.5 × 525

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for Q9950. For practitioners the limit is 5 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for Q9950 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services53 Date of Service Edit: ClinicalCMS Policy
Facility outpatient hospital53 Date of Service Edit: ClinicalCMS Policy

MUE for Q9950 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists Q9950 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check Q9950 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

Q9950 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists Q9950 in their HCPCS tables, covering 4 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing Q9950
ArticleTitleContractor(s)StatesRelated LCD
A58503Billing and Coding: Echocardiography for Myocardial PerfusionPalmetto GBANC SC VA WVL38786

Diagnoses Medicare contractors cover for Q9950

The article that lists Q9950 ties its diagnosis groups to other procedure codes, so no covered ICD-10-CM list is attributed to Q9950 itself; the diagnosis has to fit the group written for the procedure billed with the drug. See A58503.

Local coverage policies that list Q9950

1 active Local Coverage Determination lists Q9950 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

  • L38786 Echocardiography for Myocardial Perfusion · Palmetto GBA

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, Q9950 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), Q9950 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for Q9950 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for Q9950

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS Q9950

What does HCPCS code Q9950 describe?

Q9950 is defined by CMS as "Injection, sulfur hexafluoride lipid microspheres, per ml". Each billing unit represents 1 ML, so the units reported on the claim must equal the dose administered divided by that unit.

Is Q9950 a CPT code?

No. Q9950 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as sulfur hexafluoride lipid microspheres; CPT codes are five-character codes maintained by the AMA. On a Part B claim Q9950 reports the drug itself in 1 ml units, and the administration is billed on its own line.

What is the Medicare reimbursement for Q9950 in October 2026?

The ASP-based payment limit is $18.052 per 1 ML, with 20% beneficiary coinsurance. The July 2026 limit was $18.126. Commercial payers use their own fee schedules.

How many units of Q9950 can be billed per day?

The practitioner Medically Unlikely Edit is 5 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "CMS Policy" as the rationale.

Which NDCs map to Q9950?

The October 2026 ASP crosswalk lists 4 NDCs from 1 labeler: Lumason (Bracco Diagnostics Inc.); Lumason Novaplus (Bracco Diagnostics Inc.). For example NDC 00270-7097-07 (package size 5) equals 100 billing units of Q9950.

Does Q9950 have NCCI bundling edits?

No active practitioner PTP pairs list Q9950 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention Q9950?

1 current Billing and Coding Article in the Medicare Coverage Database lists Q9950, covering 4 states: A58503 (Billing and Coding: Echocardiography for Myocardial Perfusion).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.